D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

HBIO holding history

Harvard Bioscience Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HBIO overview All 13F holders of HBIO Full Q2 2026 holdings

Shares (Q1 2023): 0; Sold out in Q1 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2022

Holdings of HBIO by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2023	0	$0	0.0%	−85,569−100.0%	Sold out	Holders
Q4 2022	85,569	$237.0K	<0.1%	−154−0.2%	Reduced	Holders
Q3 2022	85,723	$220.0K	<0.1%	+45,034+110.7%	Added	Holders
Q2 2022	40,689	$146.0K	<0.1%	+40,689	New	Holders